The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krivenko L.V.

Federal Center of Brain research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Sviridova A.A.

Federal Center of Brain research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Melnikov M.V.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of FMBA;
Institute of Immunology of FMBA

Rogovskii V.S.

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency;
Pirogov Russian National Research Medical University

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Pashenkov M.V.

National Research Center Institute of Immunology of the Federal Medical Biological Agency of Russia

The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro

Authors:

Krivenko L.V., Sviridova A.A., Melnikov M.V., Rogovskii V.S., Boyko A.N., Pashenkov M.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2): 67‑72

DOI: 10.17116/jnevro202012007267

Views: 1679

Downloaded: 42

Download PDF (RU)
Contact the author
Table of contents

THE INFLUENCE OF FLUOXETINE ON INTERLEUKIN-6 AND INTERLEUKIN-1Β PRODUCTION BY DENDRITIC CELLS IN MULTIPLE SCLEROSIS IN VITRO
THE INFLUENCE OF FLUOXETINE ON INTERLEUKIN-6 AND INTERLEUKIN-1Β PRODUCTION BY DENDRITIC CELLS IN MULTIPLE SCLEROSIS IN VITRO

To cite this article:

Krivenko LV, Sviridova AA, Melnikov MV, Rogovskii VS, Boyko AN, Pashenkov MV. The influence of fluoxetine on interleukin-6 and interleukin-1β production by dendritic cells in multiple sclerosis in vitro. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2):67‑72. (In Russ.)
https://doi.org/10.17116/jnevro202012007267

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata

THE AIM OF THE STUDY

Was to evaluate the effect of selective serotonin reuptake inhibitor fluoxetine on the production of cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β) by dendritic cells in multiple sclerosis (MS).

MATERIAL AND METHODS

5 patients with relapsing-remitting MS and five healthy subjects were examined. Levels of IL-6 and IL-1β were measured by ELISA in culture supernatants obtained from lipopolysaccharide stimulated dendritic cells. To assess the effect of fluoxetine on cytokine production, dendritic cells were stimulated in the presence of fluoxetine and antagonists of 5-HT1A-, 5-HT2A-, 5-HT2B-receptors or agonist of 5-HT2B-receptors.

RESULTS

Cytokine production by dendritic cells was comparable in both groups. Fluoxetine suppressed IL-6 and IL-1β production in both groups. Blockade of 5-HT2B-receptors with specific antagonist RS 127445 reduced the inhibitory effect of fluoxetine on IL-1β production in both groups and IL-6 production in healthy subjects. In contrast, activation of 5-HT2B-receptors by specific agonist BW 723C86 increased the inhibitory effect of fluoxetine on IL-6 production by dendritic cells in both groups, but did not affect on IL-1β production.

CONCLUSION

These data suggest an anti-inflammatory effect of fluoxetine in MS by modulating pro-inflammatory cytokines production by dendritic cells. This effect could be mediate by activation of 5-HT2B-receptors.

Keywords:

fluoxetine
5-HT2B-receptors
dendritic cells
interleukin-6
interleukin-1β
multiple sclerosis

Authors:

Krivenko L.V.

Federal Center of Brain research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Sviridova A.A.

Federal Center of Brain research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Melnikov M.V.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of FMBA;
Institute of Immunology of FMBA

Rogovskii V.S.

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency;
Pirogov Russian National Research Medical University

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Pashenkov M.V.

National Research Center Institute of Immunology of the Federal Medical Biological Agency of Russia

Received:

14.05.2020

Accepted:

18.05.2020

List of references:

  1. Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015;14(4):406-419.  https://doi.org/10.1016/S1474-4422(14)70305-9
  2. Melnikov MV, Pashenkov MV, Boyko AN. Dendritic cells in multiple sclerosis. Journal of Neurology and Psychiatry. S.S. Korsakov. 2017;117(2):22-30. (In Russ.).
  3. Sie C, Korn T. Dendritic cells in central nervous system autoimmunity. Semin Immunopathol. 2017;39(2):99-111.  https://doi.org/10.1007/s00281-016-0608-7
  4. Melnikov M, Rogovskii V, Boyko A, Pashenkov M. The influence of biogenic amines on Th17-mediated immune response in multiple sclerosis. Mult Scler Relat Disord. 2018;12:21:19-23.  https://doi.org/10.1016/j.msard.2018.02.012
  5. Boyko A, Melnikov M, Ghetishev R, Pashenkov M. The role of biogenic amines in regulation of interaction between immune and nervous systems in multiple sclerosis. Neuroimmunomodulation. 2016;23(4):217-223.  https://doi.org/10.1159/000449167
  6. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.  https://doi.org/10.1002/ana.22366
  7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-1452. https://doi.org/10.1212/wnl.33.11.1444
  8. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179(4):1109-1118.
  9. Han TH, Jin P, Ren J, Slezak S, Marincola FM, Stroncek DF. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma. J Immunother. 2009;32(4):399-407.  https://doi.org/10.1097/CJI.0b013e31819e1773
  10. Branco-de-Almeida LS, Kajiya M, Cardoso CR, Silva MJ, Ohta K, Rosalen PL, Franco GC, Han X, Taubman MA, Kawai T. Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes. FEMS Immunol Med Microbiol. 2011;62(3):283-294.  https://doi.org/10.1111/j.1574-695X.2011.00816.x
  11. Pashenkov M, Huang YM, Kostulas V, Haglund M, Söderström M, Link H. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain. 2001;124(Pt 3):480-492. 
  12. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341.  https://doi.org/10.1038/nature14432
  13. De Laere M, Berneman ZN. Cools N. To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis. J Neuropathol Exp Neurol. 2018;77(3):178-192.  https://doi.org/10.1093/jnen/nlx114
  14. Prado C, Gaiazzi M, González H, Ugalde V, Figueroa A, Osorio-Barrios FJ, López E, Lladser A, Rasini E, Marino F, Zaffaroni M, Cosentino M, Pacheco R. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2018;9:571.  https://doi.org/10.3389/fimmu.2018.00571
  15. Takenaka MC, Araujo LP, Maricato JT, Nascimento VM, Guereschi MG, Rezende RM, Quintana FJ, Basso AS. Norepinephrine Controls Effector T Cell Differentiation through β2-Adrenergic Receptor-Mediated Inhibition of NF-κB and AP-1 in Dendritic Cells. J Immunol. 2016;196(2):637-644.  https://doi.org/10.4049/jimmunol.1501206
  16. Müller T, Dürk Th, Blumenthal B, Grimm M, Cicko S, Panther E, Sorichter St, Herouy Y, Di Virgilio Fr, Ferrari D, Norgauer J, Idzko M. 5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In Vivo. PLoS One. 2009;4(7):e6453. https://doi.org/10.1371/journal.pone.0006453
  17. Sviridova AA, Melnikov MV, Belousova OO, Rogovskii VS, Pashenkov MV, Boyko AN. Serotonergic system as a therapeutic target in multiple sclerosis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119:2(2):64-72. (In Russ.). https://doi.org/10.17116/jnevro20191192264
  18. Bhat R, Mahapatra S, Axtell RC, Steinman L. Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017;313:77-81.  https://doi.org/10.1016/j.jneuroim.2017.10.012
  19. Mitsonis CI, Zervas IM, Potagas CM, Mitropoulos PA, Dimopoulos NP, Sfagos CA, Papadimitriou GN, Vassilopoulos DC. Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up study. Eur Neuropsychopharmacol. 2010;20(2):123-131.  https://doi.org/10.1016/j.euroneuro.2009.10.004
  20. Mostert JP, Admiraal-Behloul F, Hoogduin JM, Luyendijk J, Heersema DJ, van Buchem MA, De Keyser J. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study. J Neurol Neurosurg Psychiatry. 2008;79(9):1027-1031. https://doi.org/10.1136/jnnp.2007.139345
  21. Idzko M, Panther E, Stratz C. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol. 2004;172:6011-6019.
  22. Szabo A, Gogolak P, Koncz G, Foldvari Z, Pazmandi K, Miltner N, Poliska S, Bacsi A, Djurovic S, Rajnavolgyi E. Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells. Sci Rep. 2018;8(1):1765. https://doi.org/10.1038/s41598-018-20173-y
  23. Katoh N, Soga F, Nara T, Tamagawa-Mineoka R, Nin M, Kotani H, Masuda K, Kishimoto S. Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol. 2006;146(2):354-361. 

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.